BIOPHTA closes its very first round of financing with a group of 9 business angels. This syndicate of investors is mainly composed of healthcare professionals as well as pharma industry experts. Beyond the money brought by this investment, BIOPHTA will benefit from the advice of a group of experts in the healthcare sector.
BIOPHTA welcomes two new non-executive directors to its board who will represent the rest of the angel group together with an additional independent board member.